Literature DB >> 277947

Secretion of lipoprotein-X by perfused livers of rats with cholestasis.

T E Felker, R L Hamilton, R J Havel.   

Abstract

The major abnormal plasma lipoprotein of cholestasis (LP-X) was isolated from blood plasma and from perfusates of isolated livers of rats with biliary obstruction. In both cases LP-X was composed mainly of about equimolar parts of phospholipids and unesterified cholesterol; the small protein component was primarily the arginine-rich apolipoprotein. By electron microscopy, LP-X appeared as a unilamellar liposome (690 A mean diameter, range 400-1000 A) with the trilaminar staining image typical of phospholipid bilayers. Extensive block staining of cholestatic livers for 48 hr with warmed uranyl acetate (37 degrees) permitted the visualization of vesicles indistinguishable from LP-X within hepatic parenchyma. These trilaminar-staining vesicles occurred predominantly within bile canaliculi. They also were seen in nearby cytoplasmic vacuoles or invaginations between hepatocytes and in the space of Disse. Similar vesicles were not seen in the endoplasmic reticulum or Golgi cisternae. These observations raise the possibility that the vesicles are formed within bile canaliculi and are transported from the canaliculi to the space of Disse within pinocytotic vacuoles.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 277947      PMCID: PMC392797          DOI: 10.1073/pnas.75.7.3459

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Protein-lipid relationships in human plasma: in biliary cirrhosis, obstructive jaundice, and acute hepatitis.

Authors:  H A EDER; E M RUSS; R A R PRITCHETT; M M WILBER; D P BARR
Journal:  J Clin Invest       Date:  1955-07       Impact factor: 14.808

2.  The relationship between serum lipids and skin xanthomata in 18 patients with primary biliary cirrhosis.

Authors:  E H AHRENS; H G KUNKEL
Journal:  J Clin Invest       Date:  1949-11       Impact factor: 14.808

3.  The lipid bilayer structure of the abnormal human plasma lipoprotein X. An X-ray small-angle-scattering study.

Authors:  P Laggner; O Glatter; K Müller; O Kratky; G Kostner; A Holasek
Journal:  Eur J Biochem       Date:  1977-07-01

4.  Secretion of the arginine-rich and A-I apolipoproteins by the isolated perfused rat liver.

Authors:  T E Felker; M Fainaru; R L Hamilton; R J Havel
Journal:  J Lipid Res       Date:  1977-07       Impact factor: 5.922

5.  Evidence that a separate particle containing B-apoprotein is present in high-density lipoproteins from perfused rat liver.

Authors:  M Fainaru; T E Felker; R L Hamilton; R J Havel
Journal:  Metabolism       Date:  1977-09       Impact factor: 8.694

6.  Radioimmunoassay of arginine-rich apolipoprotein of rat serum.

Authors:  M Fainaru; R J Havel; K Imaizumi
Journal:  Biochim Biophys Acta       Date:  1977-01-25

7.  Radioimmunoassay of apolipoprotein A-I of rat serum.

Authors:  M Fainaru; R J Havel; T E Felker
Journal:  Biochim Biophys Acta       Date:  1976-09-28

8.  A study of fixation for electron microscopy.

Authors:  G E PALADE
Journal:  J Exp Med       Date:  1952-03       Impact factor: 14.307

9.  The use of lead citrate at high pH as an electron-opaque stain in electron microscopy.

Authors:  E S REYNOLDS
Journal:  J Cell Biol       Date:  1963-04       Impact factor: 10.539

10.  Improvements in epoxy resin embedding methods.

Authors:  J H LUFT
Journal:  J Biophys Biochem Cytol       Date:  1961-02
View more
  12 in total

1.  LCAT Enzyme Replacement Therapy Reduces LpX and Improves Kidney Function in a Mouse Model of Familial LCAT Deficiency.

Authors:  Boris L Vaisman; Edward B Neufeld; Lita A Freeman; Scott M Gordon; Maureen L Sampson; Milton Pryor; Emily Hillman; Milton J Axley; Sotirios K Karathanasis; Alan T Remaley
Journal:  J Pharmacol Exp Ther       Date:  2018-12-18       Impact factor: 4.030

2.  Serum markers may distinguish biliary atresia from other forms of neonatal cholestasis.

Authors:  Hongtao Wang; James P Malone; Petra Erdmann Gilmore; Alan E Davis; John C Magee; R Reid Townsend; Robert O Heuckeroth
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-04       Impact factor: 2.839

3.  Release of bile canalicular membrane antigen into blood in experimental extrahepatic cholestasis of the rat.

Authors:  Y Kobayashi; H Ohta; T Kawasaki; M Matsumoto; K Tamakoshi; K Kanai
Journal:  Dig Dis Sci       Date:  1994-02       Impact factor: 3.199

4.  A case report of benign recurrent intrahepatic cholestasis.

Authors:  M Lee; H Hayashi; N Sakamoto; S Okuyama
Journal:  Gastroenterol Jpn       Date:  1984-10

5.  Role of cytoskeleton in canalicular contraction in cultured differentiated hepatocytes.

Authors:  H Kawahara; S W French
Journal:  Am J Pathol       Date:  1990-03       Impact factor: 4.307

6.  Appearance and characterization of lipoprotein X during continuous intralipid infusions in the neonate.

Authors:  E Griffin; W C Breckenridge; A Kuksis; M H Bryan; A Angel
Journal:  J Clin Invest       Date:  1979-12       Impact factor: 14.808

7.  Class III P-glycoproteins mediate the formation of lipoprotein X in the mouse.

Authors:  R P Elferink; R Ottenhoff; J van Marle; C M Frijters; A J Smith; A K Groen
Journal:  J Clin Invest       Date:  1998-11-01       Impact factor: 14.808

8.  Extrahepatic obstructive cholestasis reverses the bile salt secretory polarity of rat hepatocytes.

Authors:  G Fricker; L Landmann; P J Meier
Journal:  J Clin Invest       Date:  1989-09       Impact factor: 14.808

9.  Role of lipoprotein-X in the pathogenesis of cholestatic hypercholesterolemia. Uptake of lipoprotein-X and its effect on 3-hydroxy-3-methylglutaryl coenzyme A reductase and chylomicron remnant removal in human fibroblasts, lymphocytes, and in the rat.

Authors:  A K Walli; D Seidel
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

10.  Monocyte phenotyping and management of lipoprotein X syndrome.

Authors:  Zeqin Lian; Anum Saeed; Xueying Peng; Xiaoyuan Dai Perrard; Xiaoming Jia; Aliza Hussain; Christie M Ballantyne; Huaizhu Wu
Journal:  J Clin Lipidol       Date:  2020-09-04       Impact factor: 4.766

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.